VectivBio (VECT) News Today → 348 million Americans lives to END as we know it? (From The Oxford Club) (Ad) Free VECT Stock Alerts $16.85 0.00 (0.00%) (As of 05/16/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 15 at 4:17 PM | finance.yahoo.comenGene Announces the Election of Paul Hastings and Wouter Joustra to its Board of DirectorsMay 14 at 3:22 AM | finanznachrichten.deVicore Pharma Holding: Vicore Expands and Strengthens its Board of DirectorsMay 14 at 3:22 AM | finance.yahoo.comVicore Expands and Strengthens its Board of DirectorsMay 7, 2024 | americanbankingnews.comVectivBio (NASDAQ:VECT) versus Ginkgo Bioworks (NYSE:DNA) Critical AnalysisApril 5, 2024 | uk.finance.yahoo.comShort Bowel Syndrome Market by 2032: Forecast Report Estimates Significant GrowthApril 3, 2024 | marketbeat.comRegency Capital Management Inc. DE Has $8.59 Million Position in VectivBio Holding AG (NASDAQ:VECT)Regency Capital Management Inc. DE increased its stake in VectivBio Holding AG (NASDAQ:VECT - Free Report) by 1,600.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 510,000 shares of the company's stock after purchasing an additional 480,000 shMarch 18, 2024 | msn.comPipeline moves: Approval prospects for SBS candidate rise after Phase III trial meets endpointsMarch 1, 2024 | msn.comUPDATE 3-Ironwood's bowel disease drug meets main goal of late-stage studyFebruary 29, 2024 | reuters.comIronwood's bowel disease treatment meets main goal in late-stage trialFebruary 29, 2024 | benzinga.comWhy Is Gastrointestinal Healthcare Focused Ironwood Pharmaceuticals Stock Sinking On Thursday?February 29, 2024 | ft.comOnly two sleeps left until February 31!February 22, 2024 | finance.yahoo.comShort Bowel Syndrome Market Size and Share is Anticipated to Surge During the Study Period (2020–2034) | DelveInsightFebruary 16, 2024 | finance.yahoo.comIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q4 2023 Earnings Call TranscriptDecember 13, 2023 | msn.comIronwood seals the deal on VectivBio mergerDecember 12, 2023 | finance.yahoo.comIronwood Announces the Completion of Squeeze-Out Merger With VectivBioNovember 15, 2023 | tmcnet.comReverb Therapeutics Debuts Its Amplifier™ Platform for Redirecting Endogenous CytokinesNovember 10, 2023 | msn.comIronwood's (IRWD) Q3 Earnings Miss Mark, Linzess Volume RisesNovember 10, 2023 | markets.businessinsider.comAkash Tewari’s Buy Rating on Ironwood Pharma: Linzess Floor Trading and Apraglutide’s Promising FutureNovember 10, 2023 | markets.businessinsider.comHold Rating for Ironwood Pharma Driven by Stable Linzess Revenue and Anticipated Apraglutide Data, Despite T Cell Data DelayNovember 9, 2023 | finance.yahoo.comIronwood Pharmaceuticals Inc (IRWD) Reports Growth in LINZESS Sales and Maintains Full Year GuidanceOctober 27, 2023 | msn.comIronwood Pharmaceuticals: The Right Play NowOctober 16, 2023 | markets.businessinsider.comIronwood Pharmaceuticals’ Apraglutide Shows Promising Results in STARS Nutrition and VectivBio Trials: An Emphasis on Jason Butler’s Buy RatingSeptember 7, 2023 | finance.yahoo.comWhy Is Ironwood (IRWD) Down 9.6% Since Last Earnings Report?August 23, 2023 | markets.businessinsider.comEQS-News: Abivax appoints Patrick Malloy as Senior Vice President Investor RelationsAugust 23, 2023 | finance.yahoo.comAbivax Appoints Patrick Malloy as Senior Vice President Investor RelationsAugust 9, 2023 | msn.comIronwood's (IRWD) Reports Q2 Loss, Linzess Volume RisesAugust 9, 2023 | uk.finance.yahoo.comQ2 2023 Ironwood Pharmaceuticals Inc Earnings CallJuly 16, 2023 | theglobeandmail.comInstrument Name Vectivbio Holding Ag Instrument Symbol (VECT-Q)June 29, 2023 | finance.yahoo.comIronwood and VectivBio Announce the Completion of the Tender Offer for VectivBio SharesJune 27, 2023 | finanznachrichten.deVectivBio AG: VectivBio Extraordinary General Meeting of Shareholders Approved All ProposalsJune 26, 2023 | finance.yahoo.comVectivBio Extraordinary General Meeting of Shareholders Approved All ProposalsJune 16, 2023 | finance.yahoo.comIronwood and VectivBio Announce Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition of VectivBioMay 31, 2023 | benzinga.comMoore Kuehn Encourages VECT, EMBK, BACK, and RADI Investors to Contact Law FirmMay 25, 2023 | businesswire.comVECTIVBIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of VectivBio Holding AG ...May 24, 2023 | msn.comPiper Sandler Downgrades VectivBio Holding (VECT)May 23, 2023 | markets.businessinsider.comWhat 4 Analyst Ratings Have To Say About VectivBio HoldingMay 23, 2023 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Rocket Pharmaceuticals (RCKT) and VectivBio Holding (VECT)May 23, 2023 | finance.yahoo.comIronwood (IRWD) to Acquire VectivBio for $1B, Stock Up 3.6%May 23, 2023 | msn.comCredit Suisse Downgrades VectivBio Holding (VECT)May 23, 2023 | msn.comSVB Leerink Downgrades VectivBio Holding (VECT)May 23, 2023 | msn.comIronwood bulks up on digestive therapies with $1.15 billion VectivBio buyMay 22, 2023 | finance.yahoo.comVectivBio Stock Catapults 39% After Ironwood Agrees To Buy It For $1 BillionMay 22, 2023 | benzinga.comThinking about buying stock in Palantir Technologies, DraftKings, Micron Technology, Rain Oncology, or VectivBio?May 22, 2023 | finance.yahoo.comVectivBio Stock Catapults 38% After Ironwood Agrees To Buy It For $1 BillionMay 22, 2023 | finance.yahoo.comWhy Shares of VectivBio Holding Are Up TodayMay 22, 2023 | news.yahoo.comIronwood Pharma to acquire VectivBio for $1.15 billionMay 22, 2023 | msn.comIronwood Pharmaceuticals to acquire Swiss biotech VectivBio in deal valued at about $1 billionMay 22, 2023 | markets.businessinsider.comIronwood Pharma To Acquire VectivBio For $17/Shr In All-cash DealMay 10, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Iovance Biotherapeutics (IOVA) and VectivBio Holding (VECT)May 10, 2023 | markets.businessinsider.comPiper Sandler Keeps Their Buy Rating on VectivBio Holding (VECT) Get VectivBio News Delivered to You Automatically Sign up to receive the latest news and ratings for VECT and its competitors with MarketBeat's FREE daily newsletter. Email Address 348 million Americans lives to END as we know it? (Ad)348 million American lives are about to change FOREVER.... Because thanks to one shocking A.I. development I'm revealing for the first time today... To see my free research, simply click here now. VECT Media Mentions By Week VECT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VECT News Sentiment▼0.700.54▲Average Medical News Sentiment VECT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VECT Articles This Week▼30▲VECT Articles Average Week Get VectivBio News Delivered to You Automatically Sign up to receive the latest news and ratings for VECT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ACONW News DRTSW News AONC News ARTLW News BIAFW News BCTXW News BFRGW News CCLDP News CCLDO News CNTG News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VECT) was last updated on 5/17/2024 by MarketBeat.com Staff From Our Partners348 million Americans lives to END as we know it?The Oxford ClubCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceGold Set to EXPLODE!Gold Safe ExchangeInvest in the "Trojan Horse" of Alzheimer's TreatmentBehind the MarketsThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaHow Biden has already won 2024Porter & CompanyA once-in-a-century investment opportunityStansberry ResearchCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VectivBio Holding AG Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
